FDA Adverse Event Injury Summary report: N

MUSE - MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER

MDR report key: 5680490 · Received May 25, 2016

Report

Report Number
3004444684-2016-00003
Event Type
Injury
Date Received
May 25, 2016
Date of Event
April 21, 2016
Report Date
April 29, 2016
Manufacturer
MEDIGUS, LTD.
Product Code
ODE
PMA / PMN Number
K132151
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

DEVICE PERFORMED AS INTENDED. NO MALFUNCTION OR DEFECT OF DEVICE NOTED. (B)(4). MANUFACTURER: MEDIGUS LTD (B)(4). IMPORTER: (B)(4). MDR EXEMPTION E2013040.

Description of Event or Problem · 0

A MUSE ENDOSCOPIC PROCEDURE FOR THE TREATMENT OF GERD WAS SUCCESSFULLY COMPLETED. THE NEXT DAY, THE PATIENT DEVELOPED A FEVER. HE WAS TREATED WITH ANTIBIOTICS (METRONIDAZOLE) FOR THREE MORE DAYS BUT THE FEVER DID NOT RESOLVE. A CHEST X RAY SHOWED MILD PNEUMOMEDIASTINUM. AN ABDOMINAL AND CHEST CT SCAN DONE ON THE FOURTH DAY SHOWED BILATERAL PLEURAL EFFUSION, ATELECTASIS, MEDIASTINITIS AND A LEAKAGE OF CONTRAST SUBSTANCE TO THE MEDIASTINUM. AN ENDOSCOPY WAS PERFORMED BUT REVEALED NO PERFORATION. ON THE FIFTH DAY POST PROCEDURE, THE PATIENT HAD A BILATERAL CHEST TUBE INSERTION TO DRAIN THE PLEURAL EFFUSION AND A LAPAROSCOPIC PROCEDURE DURING WHICH A SMALL PERFORATION WAS IDENTIFIED. THE SURGEON NOTICED THAT PUS WAS DRAINING FROM THE PERFORATION DUE TO MEDIASTINUM ABSCESS. HE DRAINED THE MEDIASTINAL ABSCESS, THEN SUTURED AND PATCHED THE ESOPHAGEAL PERFORATION. PATIENT IMPROVED CLINICALLY AFTER THE PROCEDURES AND FEVER SUBSIDED. AS OF LAST CLINICAL UPDATE ON (B)(6), THE PATIENT WAS DOING FINE, HAD NO FEVER AND WHITE BLOOD CELL COUNT WAS IN NORMAL RANGE. CONCLUSION: MEDIASTINAL ABSCESS DUE TO ESOPHAGEAL PERFORATION. STAPLING OF DIAPHRAGM CRUSES CREATED TENSION THAT LED TO PERFORATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
333977 MUSE - MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER ENDOSTAPLER ODE MEDIGUS, LTD. SRS05

Patients

Seq Age Sex Outcome Treatment
1 34 YR Required Intervention